Goldman Sachs Merchant Banking Division and Altor Fund IV have partnered to acquire a majority stake in Hamlet Protein from Polaris Private Equity, which currently owns a 55% stake in the business.
Hamlet Protein supplies soy-based value-added animal feed used for young animals to over 50 countries from its two production sites in Horsens, Denmark, and Findlay, Ohio.
Through its partnership with Polaris Private Equity, investments into capacity expansion, and building a sales team and production facility in the U.S., Hamlet Protein has grown to become a leading world provider of specialty soy-nutrition for young animals, with strong market presence in Europe, the U.S. and Asia. Today, the business is well situated to become the top provider of animal feed for young animals in the world.
Altor and Goldman Sachs Merchant Banking Division both foresee supporting the company as it continues growing. “We see significant growth potential globally and are excited about partnering with Altor Fund IV and the management team to support the company’s impressive growth trajectory both organically and through acquisitions,” says Michael Specht Bruun, managing director of Merchant Banking Division of Goldman Sachs.
To receive relevant news stories with summaries provided by GAI News, subscribe to daily or weekly service.